Last updated on March 2020

Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Parkinson's disease
  • Age: Between 18 - 99 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients with Parkinson's disease using Duodopa for the purpose of improving circadian change (wearing-off phenomenon) of symptoms of Parkinson's disease in which sufficient effect cannot be obtained with existing drug therapy including levodopa-containing drugs.

Exclusion Criteria:

  • NA

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.